REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/15/2025
Back to search
Official data from USPTO
SPEEDX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079276870Class
1, 5, 10, 42, 44
Filing
79276870
Registration
6219009
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/16/2025
Trademark type
Combined
Nice classes
1, 5, 10, 42, 44
Filing date
09/12/2019
Registration date
12/15/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/15/2020
Last transaction
12/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
82
Owner location
AU
Examiner
FRENCH,CURTIS W
Law office
O30
Current location
PETITIONS OFFICE
Mark description
The mark consists of the following: the wording "SpeeDx" with the wording in black except for one diagonal line of the letter "X" which is blue. A stylized DNA strand of blue and purple is to the left of the wording. White is used for the background but is not claimed as a feature of the mark.
Holders and representatives
Holders
SpeeDx Pty Ltd
SpeeDx Pty Ltd
Representatives
Joi A. White Carr & Ferrell LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations used in industrysciencephotographyagriculturehorticulture and forestryexcept fungicidesherbicidesinsecticidesparasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Class 5
Pharmaceutical and veterinary preparations and substances; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceuticalveterinary and medical purposes; enzymes for pharmaceuticalveterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; clinical diagnostics for medical or veterinary use
Class 10
Surgicalmedical and veterinary apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class consisting of medical screening and testing apparatus for the diagnosis of diseasedetection and/or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy
Class 42
Scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicaldnarnaproteinpolynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencinganalysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experimentsthe results of scientific and medical experiments and teststhe analysis and evaluation of scientific and medical datadata generated by scientific and medical experiments and tests; genetic research; scientific and medical research and development services; custom design and development of biochemical assays; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry serviceschemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; molecular diagnostics testing
Class 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dnagenetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine services
Publications
History of USPTO decisions and trademark events.
34 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/13/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/12/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/18/2021
FIMP
FINAL DISPOSITION PROCESSED
03/18/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/15/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/15/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
11/17/2020
APET
ASSIGNED TO PETITION STAFF
11/17/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/30/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/29/2020
PUBO
PUBLISHED FOR OPPOSITION
09/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/25/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/21/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/13/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/13/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/13/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/13/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/13/2020
RFNT
REFUSAL PROCESSED BY IB
03/13/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/23/2020
RFRR
REFUSAL PROCESSED BY MPU
02/22/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/31/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/30/2020
CNRT
NON-FINAL ACTION WRITTEN
01/29/2020
DOCK
ASSIGNED TO EXAMINER
01/27/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/27/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/23/2020
Continuous trademark protection
Get notified about every new filing that threatens SPEEDX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.